People: Hospira, Inc. (HSP)

HSP on New York Consolidated

49.42USD
9 Feb 2010
Price Change (% chg)

$0.66 (+1.35%)
Prev Close
$48.76
Open
$49.17
Day's High
$50.13
Day's Low
$48.99
Volume
777,727
Avg. Vol
1,128,783
52-wk High
$52.79
52-wk Low
$21.21

view people for:

Begley, Christopher 

Brief Biography

Christopher B. Begley is Chairman of the Board, effective at the 2007 and Chief Executive Officer of Hospira, Inc. He has served as Chief Executive Officer and director since spin-off from Abbott Laboratories, a global broad-based healthcare company, in 2004. Prior to his becoming Chief Executive Officer, Mr. Begley provided 18 years of service to Abbott, and was Abbott's Senior Vice President, Hospital Products, between 2000 and 2004. Prior to his appointment as Senior Vice President, Hospital Products, Mr. Begley served as Abbott's Senior Vice President, Chemical and Agricultural Products, from 1999 to 2000, Vice President, Abbott Health Systems, from 1998 to 1999, and Vice President, MediSense Operations, in 1998. Mr. Begley also serves as a director of Sara Lee Corporation and AdvaMed.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
2,005,970 -- 2,631,930 5,082,430

Options Compensation

  Quantity Market Value
Excercisable 166,667 2,713,340.00
Unexercisable 558,333 7,746,410.00
Excercised 30,000 267,000.00
Name Fiscal Year Total
Begley, Christopher 5,082,430
Werner, Thomas 1,591,410
Kearney, Terrence 3,415,900
Jones, Daphne --
Ramachandra, Sumant 835,596
Smith, Brian 1,384,550
As Of 30 Dec 2008
view people for: